Cancer Letters
Volume 208, Issue 1 , Pages 43-49 , 10 May 2004

Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma

References 

  1. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann. Surg. 1981;194:438–446
  2. Osugi H, Takemura M, Takada N, Hirohashi K, Kinoshita H, Higashino M. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br. J. Surg. 2002;89:909–913
  3. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the US: the importance of tumor length and lymph node status. Cancer. 2002;95:1434–1443
  4. Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis. Esophagus. 1997;10:155–158
  5. Fujita H, Sueyoshi S, Yamana H, Shinozaki K, Toh U, Tanaka Y, et al.  Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J. Surg. 2001;25:424–431
  6. Tachibana M, Yoshimura H, Kinugasa S, Hashimoto N, Dhar DK, Abe S, et al.  Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am. J. Surg. 1997;174:49–53
  7. Conio M, Gostout CJ. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma. Analysis of 240 surgically resected tumors. Gastrointest Endosc. 2001;54:668–669
  8. Watanabe M, Kuwano H, Araki K, Kawaguchi H, Saeki H, Kitamura K, et al.  Prognostic factors in patients with submucosal carcinoma of the oesophagus. Br. J. Cancer. 2000;83:609–613
  9. Hiatt RA, Friedman GD, Bawol RD, Ury HK. Breast cancer and serum cholesterol. J. Natl Cancer Inst. 1982;68:885–889
  10. Gaziano JM, Hennekens CH. Dietary fat and risk of prostate cancer. J. Natl Cancer Inst. 1995;87:1427–1428
  11. Howe GR, Aronson KJ, Benito E, Castelleto R, Cornee J, Duffy S, et al.  The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control. 1997;8:215–228
  12. Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. J. Am. Med. Assoc. 1987;257:943–948
  13. Henriksson P, Eriksson M, Ericsson S, Rudling M, Stege R, Berglund L, et al. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet. 1989;2:1178–1180
  14. Nomura AM, Stemmermann GN, Chyou PH. Prospective study of serum cholesterol levels and large-bowel cancer. J. Natl Cancer Inst. 1991;83:1403–1407
  15. The Japanese Society for Esophageal Disease . Japanese Society for Esophageal Disease. 2001;
  16. Ikeda Y, Ozawa S, Ando N, Kitagawa Y, Ueda M, Kitajima M. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann. Thorac. Surg. 1996;62:835–838
  17. Kawamura T, Goseki N, Koike M, Takizawa T, Endo M. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathologic findings. Cancer. 1996;77:843–849
  18. Chino O, Makuuchi H, Shimada H, Machimura T, Mitomi T, Osamura RY. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen. J. Surg. Oncol. 1998;67:18–24
  19. Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn. J. Cancer Res. 2002;93:305–312
  20. Matsumoto M, Natsugoe S, Nakashima S, Okumura H, Sakita H, Baba M, et al.  Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2001;8:598–604
  21. Yamamoto H, Itoh F, Iku S, Hosokawa M, Imai K. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin. Cancer Res. 2001;7:896–900
  22. Yamamoto H, Iku S, Itoh F, Tang X, Hosokawa M, Imai K. Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer. 2001;91:1324–1331
  23. Kitayama HKJ, Kaisaki S, Suzuki H, Fujii S, Nagawa H. Hyperlipidemia is positively correlated with lymphatic metastasis in early gastric cancers in men. Br. J. Surg. 2003; in press
  24. Gal D, MacDonald PC, Porter JC, Simpson ER. Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int. J. Cancer. 1981;28:315–319
  25. Vitols S, Norgren S, Juliusson G, Tatidis L, Luthman H. Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood. 1994;84:2689–2698
  26. Sumi S, Beauchamp RD, Townsend CM, Uchida T, Murakami M, Rajaraman S, et al.  Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology. 1992;103:982–989
  27. Feleszko W, Jakobisiak M. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin. Cancer Res. 2000;6:1198–1199
  28. Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, et al.  Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin. Cancer Res. 2001;7:158–167
  29. Kort WJ, Hulsmann WC, Stehman TE. Modulation of metastatic ability by inhibition of cholesterol synthesis. Clin. Exp. Metastasis. 1989;7:517–523
  30. Jani JP, Specht S, Stemmler N, Blanock K, Singh SV, Gupta V, et al. Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis. Invasion Metastasis. 1993;13:314–324
  31. Hawk MA, Cesen KT, Siglin JC, Stoner GD, Ruch RJ. Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. Cancer Lett. 1996;109:217–222
  32. Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, Reddy BS, et al. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology. 1999;117:838–847
  33. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, et al.  3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology. 2002;122:308–317
  34. Bigler RD, Khoo M, Lund-Katz S, Scerbo L, Esfahani M. Identification of low-density lipoprotein as a regulator of Fc receptor-mediated phagocytosis. Proc. Natl Acad. Sci. USA. 1990;87:4981–4985
  35. Esfahani M, Bigler RD, Alfieri JL, Lund-Katz S, Baum JD, Scerbo L. Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochim. Biophys. Acta. 1993;1149:217–223
  36. Stewart-Phillips JL, Lough J, Phillips NC. The effect of a high-fat diet on murine macrophage activity. Int. J. Immunopharmacol. 1991;13:325–332
  37. McCarthy BM, Okano Y, Nakayasu T, Macy M, Watson SR, Harmony JA. Plasma lipoproteins and transferrin regulate the proliferation of a continuous T lymphocyte cell line. J. Lipid Res. 1987;28:1067–1077
  38. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat. Med. 2000;6:1399–1402
  39. Munford RS. Statins and the acute-phase response. N. Engl. J. Med. 2001;344:2016–2018
  40. Thun MJ, Namboodiri MM, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 1991;325:1593–1596
  41. Holland JA, Pritchard KA, Rogers NJ, Stemerman MB. Perturbation of cultured human endothelial cells by atherogenic levels of low-density lipoprotein. Am. J. Pathol. 1988;132:474–478
  42. Redl H, Schlag G, Kneidinger R, Ohlinger W, Davies J. Response of the endothelium to trauma and sepsis. Adherence, cytokine effects and procoagulatory response. Arzneimittelforschung. 1994;44:443–446
  43. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am. J. Pathol. 1992;141:1427–1433
  44. Yuan Y, Verna LK, Wang NP, Liao HL, Ma KS, Wang Y, et al.  Cholesterol enrichment upregulates intercellular adhesion molecule-1 in human vascular endothelial cells. Biochim. Biophys. Acta. 2001;1534:139–148
  45. Haller H, Schaper D, Ziegler W, Philipp S, Kuhlmann M, Distler A, et al. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension. 1995;25:511–516
  46. Gebuhrer V, Murphy JF, Bordet JC, Reck MP, McGregor JL. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem. J. 1995;306(Pt 1):293–298
  47. Mehta N, Hordines J, Sykes D, Doerr RJ, Cohen SA. Low-density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro. Clin. Exp. Metastasis. 1998;16:587–594
  48. Rader DJ, Jaye M. Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin. Lipidol. 2000;11:141–147
  49. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J. Am. Coll. Nutr. 2001;20:97–105
  50. Erickson JR, Hasegawa Y, Fang X, Eder A, Mao M, Furui T, et al.  Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. Prostaglandins. 2001;64:63–81
  51. Huang MC, Graeler M, Shankar G, Spencer J, Goetzl EJ. Lysophospholipid mediators of immunity and neoplasia. Biochim. Biophys. Acta. 2002;1582:161–167

PII: S0304-3835(03)00784-5

doi: 10.1016/j.canlet.2003.11.010

Cancer Letters
Volume 208, Issue 1 , Pages 43-49 , 10 May 2004

Article Tools